Skip to main content
Clinical Trials/NCT06707350
NCT06707350
Not Yet Recruiting
N/A

Protective Effect of Remote Ischemic Preconditioning (RIPC) Against Negative Inflammatory Response and Organ Dysfunction After Cardiovascular Surgery (Panda VII)

Nanjing Medical University1 site in 1 country500 target enrollmentDecember 1, 2024

Overview

Phase
N/A
Intervention
Not specified
Conditions
Cardiopulmonary Bypass
Sponsor
Nanjing Medical University
Enrollment
500
Locations
1
Primary Endpoint
∆SOFA
Status
Not Yet Recruiting
Last Updated
last year

Overview

Brief Summary

Remote ischaemic pre-conditioning (RIPC) has been recognized as a low-cost, non-invasive intervention method by applying brief ischaemia and reperfusion on an arm or a leg. Previous studies have mainly focused on the organoprotective effects of RIPC in patients undergoing cardiac surgery. However, whether it has an organ-protecting effect is still highly debated. We aimed to determine whether intensive RIPC can prevent from negative inflammatory response and organ dysfunction as well as postoperative complications in patients undergoing cardiovascular surgery.

Registry
clinicaltrials.gov
Start Date
December 1, 2024
End Date
December 31, 2025
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Nanjing Medical University
Responsible Party
Principal Investigator
Principal Investigator

Hong Liu

Principal Investigator of China 5A Network

Nanjing Medical University

Eligibility Criteria

Inclusion Criteria

  • patients at high risk for organ dysfunctions who underwent elective cardiovascular surgery requiring cardiopulmonary bypass (CPB);
  • age of 18 -80 years old, regardless of gender;
  • subjects voluntarily participate in the trialand sign the informed consent;

Exclusion Criteria

  • Arm fracture, skin injury or infection;
  • There is limb nerve injury;
  • Limb placement PICC, arteriovenous fistula and other devices that affect armband placement;
  • There are basic vascular lesions and poor blood supply at the extremities;
  • Limb thrombosis.

Outcomes

Primary Outcomes

∆SOFA

Time Frame: within the prior 7 days after cardiac surgery.

the change in sequential organ failure assessment score \[∆SOFA\]) was defined as the difference between the mean total postoperative SOFA score, calculated maximally to the 9th postoperative day, and the basal SOFA score.

Secondary Outcomes

  • Plasma interleukin-1 levels(within the prior 7 days after cardiac surgery.)

Study Sites (1)

Loading locations...

Similar Trials